Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Musa Alzahrani

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cancer Reports (Hoboken, N.J.)|December 12, 2023
Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working GroupFeras Alfraih, Ahmed Absi, Mohamed Abuhaleeqa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2018
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center ExperienceMusa Alzahrani, Maryse Power, Yasser Abou Mourad, et al.
Frontiers in Medicine|December 23, 2022
Clinical and biochemical characteristics of people experiencing post-coronavirus disease 2019-related symptoms: A prospective follow-up investigationAssim A Alfadda, Mohamed Rafiullah, Mohammad Alkhowaiter, et al.
American Journal of Hematology|August 12, 2015
Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphomaTarec Christoffer El-Galaly, Diego Villa, Musa Alzahrani, et al.
Journal of Inflammation Research|June 28, 2023
Early Cytokine Signatures of Hospitalized Mild and Severe COVID-19 Patients: A Prospective Observational StudyAssim A Alfadda, Khalid Siddiqui, Mohamed Rafiullah, et al.
Journal of Infection and Public Health|October 8, 2021
Clinical and biochemical characteristics and outcomes of suspected COVID-19 hospitalized patients: RT-PCR swab positive and negative comparisonAssim A Alfadda, Mohammad AlKhowaiter, Naif Alotaibi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 20, 2024
Revitalizing oncology medications access in Saudi Arabia: Current challenges and recommendations by the Saudi Oncology Pharmacy AssemblyNora Alkhudair, Jude Howaidi, Mohammed Alnuhait, et al.
Platelets|July 6, 2022
Pro106Leu MPL mutation is associated with thrombocytosis and a low risk of thrombosis, splenomegaly and marrow fibrosisMusa Alzahrani, Saeed Al Turki, Waleed Al Rajban, et al.
Blood Advances|July 10, 2019
COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter studyAllison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cancer Reports (Hoboken, N.J.)|December 12, 2023
Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working GroupFeras Alfraih, Ahmed Absi, Mohamed Abuhaleeqa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2018
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center ExperienceMusa Alzahrani, Maryse Power, Yasser Abou Mourad, et al.
Frontiers in Medicine|December 23, 2022
Clinical and biochemical characteristics of people experiencing post-coronavirus disease 2019-related symptoms: A prospective follow-up investigationAssim A Alfadda, Mohamed Rafiullah, Mohammad Alkhowaiter, et al.
American Journal of Hematology|August 12, 2015
Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphomaTarec Christoffer El-Galaly, Diego Villa, Musa Alzahrani, et al.
Journal of Inflammation Research|June 28, 2023
Early Cytokine Signatures of Hospitalized Mild and Severe COVID-19 Patients: A Prospective Observational StudyAssim A Alfadda, Khalid Siddiqui, Mohamed Rafiullah, et al.
Journal of Infection and Public Health|October 8, 2021
Clinical and biochemical characteristics and outcomes of suspected COVID-19 hospitalized patients: RT-PCR swab positive and negative comparisonAssim A Alfadda, Mohammad AlKhowaiter, Naif Alotaibi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 20, 2024
Revitalizing oncology medications access in Saudi Arabia: Current challenges and recommendations by the Saudi Oncology Pharmacy AssemblyNora Alkhudair, Jude Howaidi, Mohammed Alnuhait, et al.
Platelets|July 6, 2022
Pro106Leu MPL mutation is associated with thrombocytosis and a low risk of thrombosis, splenomegaly and marrow fibrosisMusa Alzahrani, Saeed Al Turki, Waleed Al Rajban, et al.
Blood Advances|July 10, 2019
COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter studyAllison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup, et al.
Pageof 3